Mesenchymal stem cells, sources of cells and differentiation potential

Journal of Stem Cells

Volumn 7, Issue 2, 2012, Pages 75-85

  Khan, Wasim S ^a   Hardingham, Timothy E ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOBUTYL 1 METHYL XANTHINE; DEXAMETHASONE; FIBROBLAST GROWTH FACTOR 2; INSULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE;

ADIPOCYTE; ADIPOSE TISSUE; AGING; ARTICLE; BLOOD; BONE MARROW; CARTILAGE CELL; CELL DIFFERENTIATION; CELL RENEWAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLONY FORMING UNIT; CROHN DISEASE; EMBRYONIC STEM CELL; GRAFT VERSUS HOST REACTION; HLA MATCHING; IN VITRO STUDY; KIDNEY; LIVER; LIVER CELL; MESENCHYMAL STEM CELL; MESODERM; MYOBLAST; OSTEOBLAST; PERIOSTEUM; RETINA; SKELETAL MUSCLE; SKIN; SPLEEN; STEM CELL; SYNOVIAL FAT PAD DERIVED STEM CELL; SYNOVIUM; THYMUS; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; TOOTH PULP; UMBILICAL CORD BLOOD;

ADULT STEM CELLS; ANIMALS; CELL DIFFERENTIATION; HUMANS; MESENCHYMAL STROMAL CELLS; ORGAN SPECIFICITY;

EID: 84866170005     PISSN: 15568539     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (116)

1. Adesida AB, Brady LM, Khan WS, Hardingham TE (2006). The matrix forming phenotype of human meniscus cells is enhanced by expansion in the presence of fibroblast growth factor 2 and hypoxia. Arthritis Res. Ther. 8: R61.
2. Ailhaud G (1982). Adipose cell differentiation in culture. Mol. Cell Biochem. 49: 17-31.
3. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B (2002). The transcription factor SOX9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for the expression of SOX5 and SOX6. Genes Dev. 16: 2813-28.
4. Alison MR, Poulsom R, Forbes S, Wright NA (2002). An introduction to stem cells. J. Path. 197: 419-23.
5. Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, Phinney DG (2003). Characterisation of mesenchymal stem cells isolated from murine bone marrow by negative selection. J. Cell Biochem. 89: 1235-49.
6. Benya PD, Shaffer JD (1982). Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell; 30: 215-24.
7. Beresford JN, Joyner CJ, Devlin C, Triffitt JT (1994). The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch Oral Biol. 39: 941-7.
8. Bertram H, Mayer H, Schliephake H (2005). Effect of donor characteristics, technique of harvesting and in vitro processing on culturing of human marrow stroma cells for tissue engineered growth of bone. Clin. Oral Implants Res. 16: 524-31.
9. Bianchi G, Banfi A, Mastrgiacoma M, Notaro R, Luzzatto L, Cancedda R, Quarto R (2003). Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp. Cell Res. 287: 98-105.
10. Bianco P, Riminucci M, Gronthos S, Robey PG (2001). Bone marrow stromal stem cell: nature, biology and potential applications. Stem Cells. 19: 180-92.
11. Bruder SP, Jaiswal N, Haynesworth SE (1997a). Growth kinetics, self renewal and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J. Cell Biochem. 64: 278-94.
12. DIppolito G, Schiller PC, Ricordi C, Roos BA, Howard GA (1999). Age related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J. Bone Miner Res. 14: 1115-22.
13. De Bari C, DellAccio F, Tylzanowski P, Luyten FP (2001). Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 44: 1928-42.
14. Deans RJ, Moseley AB (2000). Mesenchymal stem cells: biology and potential clinical uses. Exp. Haematol. 28: 875-84.
15. Dennis JE, Caplan AI (2000). Bone marrow mesenchymal stem cells. Stem cell handbook by Stewart Sell. Humana Press.
16. Deren JA, Kaplan FS, Brighton CT (1990). Alkaline phosphatase production by periosteal cells at various oxygen tensions in vitro. Clin. Orthop. Rel Res. 252: 307-12.
17. De Wert G, Mummery C (2003). Human embryonic stem cells: research, ethics and policy. Hum. Reprod. 18: 672-82.
18. Devine SM, Hoffman R (2002). Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Curr. Opin. Hematol. 7: 358-63.
19. Domm C, Schunke M, Christesen K, Kurz B (2002). Redifferentiation of dedifferentiated bovine articular chondrocytes in alginate culture under low oxygen tension. Osteoarthritis Cartilage. 10: 13-22.
20. Dozin B, Malpeli M, Camardella L, Cancedda R, Pietrangelo A (2002). Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines: molecular and cellular aspects. Matrix Biol. 21: 449-59.
21. Dragoo JL, Samimi B, Zhu M, Hame SL, Thomas BJ, Lieberman JR, Hedrick MH, Benhaim P (2003). Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. J. Bone Joint Surg. 85B: 740-7.
22. Draper JS, Moore HD, Ruban LN, Gokhale PJ, Andrews PW (2004). Culture and characterization of human embryonic stem cells. Stem Cells Dev. 13: 325-36.
23. Erices A, Conget P, Minguell JJ (2000). Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 109: 235-42.
24. Farrington-Rock C, Crofts NJ, Doherty MJ, Ashton BA, Griffin-Jones C, Canfield AE (2004). Chondrogenic and adipogenic potential of microvascular pericytes. Circulation. 110: 2226-32.
25. Fossett E, Khan WS, Longo UG, Smitham PJ. The effect of age and gender on cell proliferation and cell surface characterisation of synovial fat pad derived mesenchymal stem cells. J. Orthop. Res. (in press).
26. Freidenstein, AJ, Piatetzky II S, Petrakova KV (1966). Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 16: 381-90.
27. Freidenstein, AJ, Petrakova KV, Kurolesova AI, Frolova GP (1968). Heterotrophic of bone marrow. Analysis of precursoe cells for osteogenic and haematopoietic tissues. Transplantation. 6: 230-47.
28. Freidenstein AJ, Chailakhjan RK, Lalykina KS (1970). The development of fibroblast colonies in monolayer cultures of guinea pig bone marrow and spleen cells. Cell Tissue Kinet. 4: 393-403.
29. Furumatsu T, Tsuda M, Taniguchi N, Tajima Y, Asahara H (2005). Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. J. Biol. Chem. 280: 8343-50.
30. Gregoire FM (2001). Adipocyte differentiation: from fibroblast to endocrine cell. Exp. Biol. Med. 226: 997-1002.
31. Gronthos S, Zanettino ACW, Shelley JH, Shi S, Graves SE, Kortesidis A, Simmons PJ (2003). Molecular and cellular characterization of highly purified stromal stem cells derived from human bone marrow. J. Cell Sci. 116: 1827-35.
32. Hiraki Y, Shukunami C, Iyama K, Mizuta H (2001). Differentiation of chondrogenic precursor cells during the regeneration of articular cartilage. Osteoarthritis Cartilage. 9: S102-8.
33. Homicz MR, Schumacher BL, Sah RL, Watson D (2002). Effects of serial expansion of septal chondrocytes on tissue-engineered neocartilage composition. Otolaryngol Head Neck Surg. 127: 398-408.
34. Huang JI, Kazmi N, Durbhakula MM, Hering TM, Yoo JU, Johnstone B (2005). Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: A patient matched comparison. J. Orthop Res. 23: 1383-9.
35. Indrawattana N, Chen G, Tadokoro M, Shann LH, Ohgushi H, Tateishi T, Tanaka J, Bunyaratvej A (2004). Growth factor combination for chondrogenic induction from human mesenchymal stem cell. Biochem. Biophys. Res. Commun. 320: 914-9.
36. Ishino T, Hirakawa K, Takeno S, Furukido K, Sugimoto I, Yajin K (2004). Bone-constructing cells from ethmoid bone may have multilineage differentiation potential: preliminary report. Acta Otolaryngol Suppl. 553: 105-8.
37. Jaiswal PK, Wong K, Khan WS (2010). Current cell based strategies for knee cartilage injuries. J. Stem Cells. 5(4):177-85.
38. Jiang Y, Mishima H, Sakai S, Liu YK, Ohyabu Y, Uemura T (2008). Gene expression analysis of major lineage-defining factors in human bone marrow cells: effect of aging, gender, and age-related disorders. J. Orthop Res. 26: 910-7.
39. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU (1998). In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 238: 265-72.
40. Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, Markham AF, Jack A, Emery P, McGonagle D (2002). Isolation and characterisation of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum. 46: 3349-60.
41. Jones EA, English A, Henshaw K, Kinsey SE, Markham AF, Emery P, McGonagle D (2004). Enumeration and phenotypic characterisation of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum. 50: 817-27.
42. Kanitkar M, Tailor HD, Khan WS (2011). The use of growth factors and mesenchymal stem cells in orthopaedics. Open Orthop J. 5(2): 268-74.
43. Karsenty G, Wagner EF (2002). Reaching a genetic and molecular understanding of skeletal development. Dev. Cell. 2: 389-406.
44. Kennard L, Tailor HD, Thanabalasundaram G, Khan WS (2011). Advances and developments in the use of human mesenchymal stem cells-A few considerations. Open Orthop J. 5: 249-52.
45. Khan WS, Adesida AB, Hardingham TE (2007). Hypoxic conditions increase hypoxia-inducible transcription factor 2alpha and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients. Arthritis Res. Ther. 9: R55.
46. Khan WS, Tew SR, Adesida AB, Hardingham TE (2008). Human infrapatellar fat pad-derived stem cells express the pericyte marker 3G5 and show enhanced chondrogenesis after expansion in fibroblast growth factor-2. Arthritis Res Ther. 10: R74.
47. Khan WS, Adesida AB, Tew SR, Hardingham TE (2009). The epitope characterisation and osteogenic differentiation potential of fat pad derived stem cells is maintained with ageing in later life. Injury; 40(2): 150-7.
48. Khan WS, Marsh DR (2009). A Literature Review on the Effects of Ageing on Mesenchymal Stem Cells. Current Research Journal of Biological Sciences; 1(1): 1-6.
49. Khan WS, Johnson DS, Hardingham DS (2010a). The Potential Use of Stem Cells for Knee Articular Cartilage Repair. Knee. 17(6): 369-74.
50. Khan WS, Adesida AB, Tew SR, Lowe ET, Hardingham TE (2010b). Bone Marrow Derived Mesenchymal Stem Cells Express the Pericyte Marker 3G5 in Culture and Show Enhanced Chondrogenesis in Hypoxic Conditions. J. Orthop Res. 28(6): 834-40.
51. Koller MR, Bender JG, Papoutsakis ET, Miller WM (1992). Effects of synergistic cytokine combinations, low oxygen, and irradiated stroma on the expansion of human cord blood progenitors. Blood. 80: 403-11.
52. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, Dazzi F (2003). Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood. 101: 3722-9.
53. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, Ringdén O (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. The Lancet. 363: 1439-41.
54. Lennon DP, Edmison JM, Caplan AI (2001). Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis. J. Cell Physiol. 187: 345-55.
55. Li Y, Tew SR, Russel AM, Gonzalez KR, Hardingham TE, Hawkins RE (2004). Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9. Tissue Eng. 10: 575-84.
56. Loty S, Forest N, boulekbache H, Sautier JM (1995). Cytochalasin D induces changes in cell shape and promotes in vitro chondrogenesis: a morphological study. Biol Cell. 83: 149-61.
57. MacDougald OA, Mandrup S (2002). Adipogenesis: forces that tip the scales. Trends Endocrinol Metab. 13: 5-11.
58. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF (1998). Chondrogenic differentiation of cultured marrow mesenchymal stem cells from marrow. Tissue Eng. 4: 415-28.
59. Mafi P, Hindocha S, Mafi R, Griffin M, Khan WS (2011). Sources of adult mesenchymal stem cells applicable for musculoskeletal applications-A systematic review of the literature. Open Orthop J. 5(2): 242-8.
60. Magne D, Vinatier C, Julien M, Weiss P, Guicheux J (2005a). Mesenchymal stem cell therapy to rebuild cartilage. Trends Mol Med. 11: 519-26.
61. Mareschi K, Ferrero I, Rustichelli D, Aschero S, Gammaitoni L, Aglietta M, Madon E, Fagioli F (2006). Expansion of mesenchymal stem cells isolated from paediatric and adult donor bone marrow. J. Cell Biochem. 97: 744-54.
62. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R (1997). Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology. 138: 4456-62.
63. Meyrick B, Fujiwara K, Reid L (1981). Smooth muscle myosin in precursor and mature smooth muscle cells in normal pulmonary arteries and the effect of hypoxia. Exp. Lung Res. 2: 303-13.
64. Miranville A, Heeschen C, Sengenes C, Curat CA, Busse R, Bouloumie A (2004). Improvement of postnatal neovascularisation by human adipose tissue derived stem cells. Circulation. 110: 349-55.
65. Mochizuki T, Muneta T, Sakaguchi Y, Nimura A, Yokoyama A, Koga H, Sekiya I (2006). Higher chondrogenic potential of fibrous synovium-and adipose synovium-derived cells compared with subcutaneous fat-derived cells. Arthritis Rheum. 54: 843-53.
66. Mohal JS, Tailor HD, Khan WS. Sources of adult mesenchymal stem cells and their applicability for musculoskeletal applications. Curr. Stem Cell Res Ther. (in press)
67. Morrison SJ, Csete M, Groves AK, Melega W, Wold B, Anderson DJ (2000). Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells. J. Neurosci. 20: 7370-6.
68. Murphy CL, Sambanis A (2001). Effect of oxygen tension and alginate encapsulation on restoration of the differentiated phenotype of passaged chondrocytes. Tissue Eng. 7: 791-803.
69. Orkin SH, Morrison SJ (2002). Stem-cell competition. Nature. 418:25-7.
70. Owen ME, Cave J, Joyner CJ (1987). Clonal analysis in vitro of osteogenic differentiation of marrow CFU-F. J. Cell Sci. 87: 731-8.
71. Owen M, Friedenstein AJ (1988). Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp. 136: 42-60.
72. Pastides PS, Khan WS (2011). Cell-Based Therapies in Musculoskeletal Injuries: The Evolving Role of Bone Marrow-Derived Mesenchymal Stem Cells. Br. J. Med. Med. Res. 1(4): 112.
73. Peng H, Huard J (2003). Stem cells in the treatment of muscle and connective tissue diseases. Curr. Opin Pharmacol. 3: 329-33.
74. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999). Multilineage potential of adult human mesenchymal stem cells. Science. 284: 143-7.
75. Pittenger MF, Mbalaviele G, Black M, Mosca JD, Marshak DR (2001). Mesenchymal stem cells. In: Koller MR, Palsson BO, Masters JRW Eds. Primary mesenchymal cells. Dordrecht; Boston: Kluwer Academic Publishers: 189-207.
76. Pittinger MF, Martin BJ (2004). Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95: 9-20.
77. Poole AR (1995). Imbalance of anabolism and catabolism of cartilage matrix componenets in osteoarthritis. In: Kuettner KE, Goldberg B Eds. Osteoarthritic disorders. Rosemont: AAOS: 247-60.
78. Prockop DJ (1997). Marrow stromal cells as stem cells for nonhaematopoietic tissues. Science. 276: 71-4.
79. Qiu Z, Wei Y, Chen N, Jiang M, Wu J, Liao K (2001). DNA synthesis and mitotic clonal expansion is not a required step for 3T3-L1 preadipocyte differentiation into adipocytes. J. Biol. Chem. 276: 11988-95.
80. Ramirez-Zacarias JL, Castro-Munozledo F, Kuri-Harcuch W (1992). Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochem. 97: 493-7.
81. Rich IN, Kubanek B (1982). The effect of reduced oxygen tension on colony formation of erythropoietic cells in vitro. Br. J. Haematol. 52: 579-88.
82. Rich IN (1986). A role for the macrophage in normal hemopoiesis. II. Effect of varying physiological oxygen tensions on the release of hemopoietic growth factors from bone marrow derived macrophages in vitro. Exp. Haematol. 14: 746-51.
83. Rim JS, Mynatt RL, Gawronska-Kozak B (2005). Mesenchymal stem cells from the outer ear: a novel adult stem cell model system for the study of adipogenesis. FASEB J. 19: 1205-7.
84. Rosen ED, Spiegelman BM (2000). Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 16: 145-71.
85. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T (2005). Comparison of human stem cells derived from various mesenchymal tissues-Superiority of synovium as a cell source. Arthritis Rheum. 52: 2521-9.
86. Scharstuhl A, Schewe B, Benz K, Gaissmaier C, Bühring HJ, Stoop R (2007). Chondrogenic potential of human adult mesenchymal stem cells is independent of age or osteoarthritis etiology. Stem Cells. 25: 3244-51.
87. Scherer K, Schunke M, Sellckau R, Hassenpflug J, Kurz B (2004). The influence of oxygen and hydrostatic pressure on articular chondrocytes and adherent bone marrow cells in vitro. Biorheology. 41: 323-33.
88. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, Johnson RS (2001). Hypoxia in cartilage: HIF1 is essential for chondrocyte growth arrest and survival. Genes Dev. 15: 2865-76.
89. Schipper BM, Marra KG, Zhang W, Donnenberg AD, Rubin JP (2008). Regional anatomic and age effects on cell function of human adipose-derived stem cells. Ann. Plast Surg. 60: 538-44.
90. Sekiya I, Vuoristo JT, Larson BL, Prockop DJ (2002). In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc. Natl. Acad. Sci. USA. 99: 4397-402.
91. Shamsul BS, Aminuddin BS, Ng MH, Ruszymah BH (2004). Age and gender effect on the growth of bone marrow stromal cells in vitro. Med. J. Malaysia. 59B:196-7.
92. Short B, Brouard N, Occhioduro-Scott T, Ramakrishnand A, Simmons PJ (2003). Mesenchymal stem cells. Arch Med. Res. 34: 565-71.
93. Siddappa R, Licht R, van Blitterswijk C, de Boer J (2007). Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J. Orthop Res. 25: 1029-41.
94. Silver IA (1975). Measurement of pH and ionic composition of pericellular sites. Philos Trans R Soc Lond B Biol Sci. 271: 261-72.
95. Solchaga LA, Penick K, Porter JD, Goldberg VM, Caplan AI, Welter JF (2005). FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J. Cell Physiol. 203: 398-409.
96. Sottile V, Seuwen K (2001). A high capacity screen for adipogenic differentiation. Anal. Biochem. 293: 124-8.
97. Spees JL, Gregory CA, Singh H, Tucker HA, Peister A, Lynch PJ, Hsu SC, Smith J, Prockop DJ (2004). Internalised antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol. Ther. 9: 747-56.
98. Stenderup K, Justesen J, Clausen C, Kassem M (2003). Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 33: 919-26.
99. Stolzing A, Jones E, McGonagle D, Scutt A (2008). Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech. Ageing Dev. 129: 163-73.
100. Suva D, Garavaglia G, Menetrey J, Chapuis B, Hoffmeyer P, Bernheim L, Kindler V (2004). Non-hematopoietic human bone marrow contains long-lasting, pluripotential mesenchymal stem cells. J. Cell Physiol. 198: 110-8.
101. Tew SR, Hardingham TE (2006). Regulation of SOX9 mRNA in Human Articular Chondrocytes Involving p38 MAPK Activation and mRNA Stabilization. J. Biol. Chem. 281: 39471-9.
102. Thanabalasundaram G, Arumalla N, Tailor HD, Khan WS (2012). Regulation of differentiation of mesenchymal stem cells into musculoskeletal cells. Curr. Stem Cell Res Ther. 7(2): 95-102.
103. Thomas WE (1999). Brain macrophages: on the role of pericytes and perivascular cells. Brain Res. Brain Res. Rev. 31: 42-57.
104. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998). Embryonic stem cell lines derived from human blastocysts. Science. 282: 1145-7.
105. Triffitt JT (2002). Stem cells and the philosophers stone. J. Cell Biochem. Suppl. 38: 38: 13-9.
106. Tucker BA, Karamsadkar SS, Khan WS, Pastides P (2010). The Role of Bone Marrow Derived Mesenchymal Stem Cells in Sports Injuries. J. Stem Cells. 5(4): 155-66.
107. Vaananen HK (2005). Mesenchymal stem cells. Ann. Med. 37: 469-79.
108. Vats A, Tolley NS, Bishop AE, Polak JM (2005). Embryonic stem cells and tissue engineering: delivering stem cells to the clinic. J. R. Soc. Med. 98: 346-50.
109. Wang DW, Fermor B, Gimble JM, Awad HA, Guilak F (2005). Influence of oxygen on the proliferation and metabolism of adipose derived adult stem cells. J. Cell Physiol. 204: 184-91.
110. Watt FM (1988). Effect of seeding density on stability of the differentiated phenotype of pig articular chondrocytes in culture. J. Cell Sci. 89: 373-8.
111. Wesseling P, Schlingemann RO, Rietveld FJ, Link M, Burger PC, Ruth DJ (1995). Early and extensive contribution of pericytes/ vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: an immuno-light and immuno-electron microscopy study. J. Neuropathol Exp Neurol. 54: 304-10.
112. Wickham MQ, Erickson GR, Gimble JM, Vail TP, Guilak F (2003). Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin. Orthop. 412: 196-212.
113. Wroblewski J, Edwall-Arvidsson C (1995). Inhibitory effects of basic fibroblast growth factor on chondrocyte differentiation. J. Bone Miner Res. 10: 735-42.
114. Zhou G, Garofalo S, Mukhopadhyay K, Lefebvre V, Smith CN, Eberspaecher H, de Crombrugghe B (1995). A 182 bp fragment of the mouse pre alpha 1 (II) collagen gene is sufficient to direct chondrocyte expression in transgenic mice. J. Cell Sci. 108: 3677-84.
115. Zuk PA, Zhu M, Mizino H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7: 211-28.
116. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizino H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH (2002). Human adipose tissue is a source of multipotent stem cells. Mol. Biol Cell. 13: 4279-95.